At a glance
- Originator Institut de Genetique et de Biologie Moleculaire et Cellulaire; Institute for Diabetes Discovery LLC
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic complications
Most Recent Events
- 15 Sep 1999 New profile
- 15 Sep 1999 Preclinical development for Diabetic complications in France (Unknown route)
- 15 Sep 1999 Preclinical development for Diabetic complications in USA (Unknown route)